Stay updated on Atezolizumab+Bevacizumab 1st Line in NSCLC (TELMA) Clinical Trial

Sign up to get notified when there's something new on the Atezolizumab+Bevacizumab 1st Line in NSCLC (TELMA) Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Atezolizumab+Bevacizumab 1st Line in NSCLC (TELMA) Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    New version entry dated 2025-02-12 shows updated Recruitment Status and ongoing Study Status details in the record history. The change reflects current trial activity and availability information as recorded on ClinicalTrials.gov.
    Difference
    0.2%
    Check dated 2025-11-03T20:43:54.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The record history shows two new Results Submission Events and one removed, reflecting updates to how results submissions are tracked. This is an administrative log update and does not modify the study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-10-27T15:11:04.000Z thumbnail image
  4. Check
    38 days ago
    Change Detected
    Summary
    Introducing version v3.2.0 and a government-operating-status notice; removing the older v3.1.0 reference.
    Difference
    12%
    Check dated 2025-10-06T05:08:11.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    Version updated from v3.0.2 to v3.1.0; no other content changes detected.
    Difference
    0.3%
    Check dated 2025-09-29T02:57:31.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    Now shows Revision: v3.0.2, replacing v3.0.1, and the Back to Top element has been removed. These are cosmetic changes with no impact on core content or critical information.
    Difference
    0.7%
    Check dated 2025-09-14T18:57:01.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.7%
    Check dated 2025-09-07T14:08:25.000Z thumbnail image

Stay in the know with updates to Atezolizumab+Bevacizumab 1st Line in NSCLC (TELMA) Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Atezolizumab+Bevacizumab 1st Line in NSCLC (TELMA) Clinical Trial page.